T. Alex Mcpherson - Net Worth and Insider Trading
T. Alex Mcpherson Net Worth
The estimated net worth of T. Alex Mcpherson is at least $1 dollars as of 2024-11-10. T. Alex Mcpherson is the Director of NovaBay Pharmaceuticals Inc and owns about 1 shares of NovaBay Pharmaceuticals Inc (NBY) stock worth over $1. Details can be seen in T. Alex Mcpherson's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that T. Alex Mcpherson has not made any transactions after 2011-05-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of T. Alex Mcpherson
T. Alex Mcpherson Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, T. Alex Mcpherson owns 1 companies in total, including NovaBay Pharmaceuticals Inc (NBY) .
Click here to see the complete history of T. Alex Mcpherson’s form 4 insider trades.
Insider Ownership Summary of T. Alex Mcpherson
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
NBY | NovaBay Pharmaceuticals Inc | 2011-05-27 | director |
T. Alex Mcpherson Latest Holdings Summary
T. Alex Mcpherson currently owns a total of 1 stock. T. Alex Mcpherson owns 1 shares of NovaBay Pharmaceuticals Inc (NBY) as of May 27, 2011, with a value of $1.
Latest Holdings of T. Alex Mcpherson
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
NBY | NovaBay Pharmaceuticals Inc | 2011-05-27 | 1 | 0.69 | 1 |
Holding Weightings of T. Alex Mcpherson
T. Alex Mcpherson Form 4 Trading Tracker
According to the SEC Form 4 filings, T. Alex Mcpherson has made a total of 0 transactions in NovaBay Pharmaceuticals Inc (NBY) over the past 5 years. The most-recent trade in NovaBay Pharmaceuticals Inc is the acquisition of 0 shares on May 27, 2011, which cost T. Alex Mcpherson around $10,230.
Insider Trading History of T. Alex Mcpherson
- 1
T. Alex Mcpherson Trading Performance
GuruFocus tracks the stock performance after each of T. Alex Mcpherson's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by T. Alex Mcpherson is -45.91%. GuruFocus also compares T. Alex Mcpherson's trading performance to market benchmark return within the same time period. The performance of stocks bought by T. Alex Mcpherson within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how T. Alex Mcpherson's insider trading performs compared to the benchmark.
Performance of T. Alex Mcpherson
T. Alex Mcpherson Ownership Network
Ownership Network List of T. Alex Mcpherson
Ownership Network Relation of T. Alex Mcpherson
T. Alex Mcpherson Owned Company Details
What does NovaBay Pharmaceuticals Inc do?
Who are the key executives at NovaBay Pharmaceuticals Inc?
T. Alex Mcpherson is the director of NovaBay Pharmaceuticals Inc. Other key executives at NovaBay Pharmaceuticals Inc include Interim CFO Tommy Law , President & DERMAdoctor & LLC Jeffrey Kunin , and Chief Product Officer Audrey Kunin .
NovaBay Pharmaceuticals Inc (NBY) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of NovaBay Pharmaceuticals Inc (NBY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NovaBay Pharmaceuticals Inc (NBY) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
NovaBay Pharmaceuticals Inc (NBY)'s detailed insider trading history can be found in Insider Trading Tracker table.
NovaBay Pharmaceuticals Inc Insider Transactions
T. Alex Mcpherson Mailing Address
Above is the net worth, insider trading, and ownership report for T. Alex Mcpherson. You might contact T. Alex Mcpherson via mailing address: C/o Novabay Pharmaceuticals, Inc., 5980 Horton Street, Suite 550, Emeryville Ca 94608.